PharmaShots | Incisive News in 3 Shots

Subscribe Now

quamous Non-Small Cell lung cancer (NSCLC)

BeiGene's Tislelizumab (BGB-A317) + CT Receive NMPA's Approval as 1L Therapy for Advanced Squamous NSCLC

BeiGene's Tislelizumab (BGB-A317) + CT Receive NMPA's Approval as 1L Therapy for Advanced Squamous NSCLC

January 14, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us